UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases

British journal of cancer, 2001-01, Vol.84 (1), p.72-79

2001

Volltextzugriff (PDF)

Clinical course and prognostic factors of Merkel cell carcinoma of the skin

British journal of dermatology (1951), 2009-07, Vol.161 (1), p.90-94

2009

Volltextzugriff (PDF)

Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer

European journal of cancer (1990), 2001, Vol.37 (2), p.251-259

2001

Volltextzugriff (PDF)

Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma

Archives of Dermatological Research, 2000-05, Vol.292 (5), p.225-232

2000

Volltextzugriff (PDF)

Cutaneous squamous cell carcinoma

Hautarzt, 2020-08, Vol.71 (8), p.597-606

2020

Volltextzugriff (PDF)

Aktuelle Systemtherapie des metastasierten malignen Melanoms

Aktuelle Dermatologie, 2017-04, Vol.43 (4), p.133-138

2017

Volltextzugriff (PDF)

Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseases

Journal of the American Academy of Dermatology, 1999-06, Vol.40 (6), p.957-960

1999

Volltextzugriff (PDF)

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)

Annals of oncology, 2008-04, Vol.19 (4), p.801-806

2008

Volltextzugriff (PDF)

Nachsorge des Melanoms – neue Aspekte

Der Onkologe, 2010-12, Vol.16 (12), p.1175-1181

2010

Volltextzugriff (PDF)

Cutaneous squamous cell carcinoma

Hautarzt, 2016-11, Vol.67 (11), p.857

2016

Volltextzugriff (PDF)

Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg)

British journal of dermatology (1951), 2006-06, Vol.154 (6), p.1123-1127

2006

Volltextzugriff (PDF)

Aktuelle Systemtherapie des metastasierten malignen Melanoms – Zielgerichtete Therapien und Immuntherapie als vielversprechende Optionen

Der Klinikarzt, 2017-04, Vol.45 (4), p.202-207

2017

Volltextzugriff (PDF)

S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase

Anticancer research, 2001-03, Vol.21 (2B), p.1311

2001

Volltextzugriff (PDF)

1044P Sequential targeted and immunotherapies in stage IV melanoma

Annals of oncology, 2021-09, Vol.32, p.S875-S875

2021

Volltextzugriff (PDF)

EPH80 Survival and Best Recorded Response (BRR) in Patients With Advanced Merkel Cell Carcinoma (MCC): Analysis of a Prospective German MCC Registry Study (MCC TRIM) of the German Dermatologic Cooperative Oncology Group

Value in health, 2023-12, Vol.26 (12), p.S217

2023

Volltextzugriff (PDF)

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003198

2022

Volltextzugriff (PDF)

Micrographic Surgery Allows Fascia Preservation in Dermatofibrosarcoma Protuberans

Acta dermato-venereologica, 2021-09, Vol.101 (9), p.adv00561-adv00561

2021

Volltextzugriff (PDF)

The natural course of cutaneous melanoma

Journal of surgical oncology, 2004-07, Vol.86 (4), p.172-178

2004

Volltextzugriff (PDF)

Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography

Journal of the European Academy of Dermatology and Venereology, 2003-07, Vol.17 (4), p.402-407

2003

Volltextzugriff (PDF)

Efficacy and safety of dabrafenib and trametinib in patients with metastatic BRAFV600 mutation-positive melanoma in the real-world setting: Interim results of the non-interventional COMBI-r study

Annals of oncology, 2019-10, Vol.30, p.v544-v545

2019

Volltextzugriff (PDF)

1335PEfficacy and safety of dabrafenib and trametinib in patients with metastatic BRAFV600 mutation-positive melanoma in the real-world setting: Interim results of the non-interventional COMBI-r study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1335P - Efficacy and safety of dabrafenib and trametinib in patients with metastatic BRAFV600 mutation-positive melanoma in the real-world setting: Interim results of the non-interventional COMBI-r study

Annals of oncology, 2019-10, Vol.30, p.v544-v545

2019

Volltextzugriff (PDF)

Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil

British journal of dermatology (1951), 1999-07, Vol.141 (1), p.175-176

1999

Volltextzugriff (PDF)

1286PEUMelaReg: A European platform for outcome research on real world treatment data of patients with advanced melanoma

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Prognostic Factors of Thin Cutaneous Melanoma: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3660-3667

2004

Volltextzugriff (PDF)

26 – 50 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(80)
Humans
(66)
Dermatology
(52)
Male
(48)
Female
(43)
Biological And Medical Sciences
(41)
Medical Sciences
(39)
Middle Aged
(37)
Aged
(29)
Adult
(26)
Oncology
(25)
Animals
(19)
Melanoma - Pathology
(17)
Melanoma
(16)
Skin Neoplasms - Pathology
(16)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(16)
Medicine
(14)
Medicine & Public Health
(14)
Prognosis
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases

Clinical course and prognostic factors of Merkel cell carcinoma of the skin

Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer

Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma

Cutaneous squamous cell carcinoma

Aktuelle Systemtherapie des metastasierten malignen Melanoms

Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseases

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)

Nachsorge des Melanoms – neue Aspekte

Cutaneous squamous cell carcinoma

Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg)

Aktuelle Systemtherapie des metastasierten malignen Melanoms – Zielgerichtete Therapien und Immuntherapie als vielversprechende Optionen

S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase

1044P Sequential targeted and immunotherapies in stage IV melanoma

EPH80 Survival and Best Recorded Response (BRR) in Patients With Advanced Merkel Cell Carcinoma (MCC): Analysis of a Prospective German MCC Registry Study (MCC TRIM) of the German Dermatologic Cooperative Oncology Group

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Micrographic Surgery Allows Fascia Preservation in Dermatofibrosarcoma Protuberans

The natural course of cutaneous melanoma

Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography

Efficacy and safety of dabrafenib and trametinib in patients with metastatic BRAFV600 mutation-positive melanoma in the real-world setting: Interim results of the non-interventional COMBI-r study

1335PEfficacy and safety of dabrafenib and trametinib in patients with metastatic BRAFV600 mutation-positive melanoma in the real-world setting: Interim results of the non-interventional COMBI-r study

1335P - Efficacy and safety of dabrafenib and trametinib in patients with metastatic BRAFV600 mutation-positive melanoma in the real-world setting: Interim results of the non-interventional COMBI-r study

Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil

1286PEUMelaReg: A European platform for outcome research on real world treatment data of patients with advanced melanoma

Prognostic Factors of Thin Cutaneous Melanoma: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society

Suchergebnisse filtern